The Asia Pacific market is expected to grow from USD 187 billion in 2009 to nearly USD 275 billion in 2013, at a CAGR of 13%. This is mainly owing to low cost availability of medicines, rising income levels, and growth of business and health insurance schemes, ensuring sales of branded drugs.1 Although small in terms of market size Vietnam, Cambodia and Myanmar, are predicted to generate strong demands for pharmaceutical products in the future. This is primarily because the pharmaceutical industry in these countries is still at their infancy and expected to grow by leaps and bounds.2
Data Sources:
1. Pharma Times - Vol. 43 - No. 09 - September 2011
2. Frost & Sullivan Asia Pacific, The Generic Invasion - An Inside Scoop to the Pot of Gold
